_1777294237270_124456903.png&w=64&q=75){kind=small}
Acdima stake in Al-Dawaa sold at 27.90 riyals
GIB Capital announced the completion of the full sale of Akdima Company's stake in the Saudi Pharmaceutical Industries and Medical Supplies Company (Al-Dawaa) at a price of 27.90 SAR per share. The sale was conducted through a negotiated deals mechanism. A total of 12,588,173 shares were offered, and the offering was successfully covered by investors within the Kingdom, resulting in Akdima completely exiting its ownership in the Saudi Pharmaceutical Industries Company. This marks a strategic shift in the company's ownership structure.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)